Keros Therapeutics, Inc.
KROS
Revenue
211.19M
▲210.80M▲54330.93%
6 Months ChangeAssets
784.56M
▲168.68M▲27.39%
3 Months ChangeLiabilities
55.69M
▲11.36M▲25.62%
3 Months ChangeFree Cash Flow
160.61M
▲206.11M▲452.93%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-16
Form 8-K
ID: 0001664710-24-000081
2024-09-30
Form 8-K
ID: 0001664710-24-000078
2024-09-03
Form 8-K
ID: 0001664710-24-000075
2024-08-28
Form 8-K
ID: 0001664710-24-000072
2024-08-07
Form 8-K
ID: 0001664710-24-000069
2024-08-07
Form 10-Q
ID: 0001664710-24-000068
2024-08-07
Form 8-K
ID: 0001664710-24-000067
2024-06-17
Form 8-K
ID: 0001664710-24-000059
2024-06-17
Form 8-K
ID: 0001664710-24-000058
2024-06-17
Form 8-K
ID: 0001664710-24-000055